CB Chubb Limited
Elite underwriter now priced slightly above normalized value; soft-market risk caps upside at 14% ROE.
The story
Chubb remains the best-in-class global P&C underwriter, with a diversified commercial, specialty, A&H and Asia life franchise and a conservatively reserved, high-quality balance sheet. Trailing ROE of 15.2% reflects peak-ish underwriting margins and elevated reinvestment yields, but commercial P&C pricing is softening and catastrophe losses are lumpy. Book value keeps compounding through retained earnings and buybacks, but the stock re-rated about 8% since our last take without a matching change in normalized fundamentals.
I kept every driver unchanged. The trailing 15.2% ROE is above our 14% through-the-cycle figure because the soft-market phase and normal catastrophe years still lie ahead, and higher investment income only partly offsets that. Book growth of 7% now, fading to 4.5%, fits earnings retention net of buybacks and dividends. A beta of 0.8 and a very low failure probability reflect the AA-rated balance sheet and conservative reserving.
Value drivers
| Return on equity (normalized) | 14.0% |
| Book-value growth (Y1) | 7.0% |
| Terminal book growth | 4.5% |
| Beta | 0.80 |
| Failure probability | 0.2% |
| Cost of equity | 8.6% |
Valuation bridge
| PV of excess returns | 23.33B |
| PV of terminal excess | 27.59B |
| Equity value | 124.43B |
| ÷ shares → per share | $325.66 |
Projected excess returns on equity
| Yr | Book equity | ROE | Excess return | PV |
|---|---|---|---|---|
| 1 | 73.76B | 14.0% | 3.98B | 3.67B |
| 2 | 78.92B | 13.6% | 3.96B | 3.36B |
| 3 | 84.23B | 13.2% | 3.91B | 3.06B |
| 4 | 89.65B | 12.9% | 3.83B | 2.75B |
| 5 | 95.18B | 12.5% | 3.70B | 2.45B |
| 6 | 100.79B | 12.1% | 3.54B | 2.16B |
| 7 | 106.44B | 11.7% | 3.34B | 1.87B |
| 8 | 112.12B | 11.4% | 3.09B | 1.60B |
| 9 | 117.79B | 11.0% | 2.80B | 1.33B |
| 10 | 123.41B | 10.6% | 2.47B | 1.08B |
Key risks
- Commercial P&C pricing softening compresses combined ratios faster than expected
- Large catastrophe or social-inflation reserve strengthening in US casualty lines
- Falling rates erode reinvestment yields and net investment income
Catalysts
- Sustained low-80s combined ratio plus rising net investment income pushing ROE above 15% through a soft market
- Accretive international or Asia life acquisition deploying excess capital